Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Saniona AB | 9.350% | 14.977% | 15.854% | -73.286% | -54.148% | -92.149% | - |
| Sirona Biochem Corp. | 9.200% | 1.149% | -1.124% | -50.893% | -32.308% | -78.641% | -83.012% |
| Alimera Sciences | 9.190% | - | - | - | - | - | - |
| Cara Therapeutics Inc. | 8.890% | 3.678% | 16.349% | -79.129% | 5.696% | -93.342% | -95.611% |
| Osmotica Pharmaceuticals PLC | 8.780% | - | - | - | - | - | - |
| Bayer AG ADR | 8.700% | -0.662% | 19.048% | -43.609% | -12.791% | -45.652% | -46.429% |
| Cellmid Ltd | 7.940% | - | - | - | - | - | - |
| Genfit S.A. | 7.760% | 11.226% | 19.334% | -4.198% | 4.438% | 14.368% | -82.190% |
| Purple Biotech Ltd. ADR | 7.590% | 0.990% | 19.159% | -71.508% | -31.544% | -85.593% | - |
| AC Immune Ltd | 7.570% | -5.375% | 30.562% | 55.681% | -33.676% | -44.135% | - |
| Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
| Grindeks AS | 7.330% | - | - | - | - | - | - |
| GNI Group Ltd | 7.200% | -2.190% | -7.586% | 88.732% | -23.864% | -8.219% | 84.446% |
| Canopy Growth Corp | 7.100% | - | - | - | - | - | - |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| Atara Biotherapeutics Inc. | 6.740% | 15.510% | -5.758% | -69.415% | 16.641% | -94.921% | - |
| AquaBounty Technologies Inc | 6.640% | - | - | - | - | - | - |
| Starpharma Holdings Ltd. | 6.420% | -12.121% | -17.143% | -78.519% | -38.624% | -94.423% | -92.516% |
| Biotec Pharmacon ASA | 6.350% | 0.919% | -11.982% | -42.138% | -45.111% | -76.476% | 385.504% |
| BioLine RX Ltd ADR | 6.030% | -3.279% | -4.839% | -56.296% | -58.451% | -77.481% | -99.181% |
| InMed Pharmaceuticals Inc. | 5.990% | 19.158% | 9.690% | -76.917% | -17.733% | -99.476% | -99.883% |
| Immutep Ltd. | 5.970% | 5.185% | 36.538% | 36.538% | 36.538% | -19.318% | 118.462% |
| Heron Therapeutics Inc. | 5.830% | 20.575% | 25.546% | 179.820% | 97.834% | -73.339% | - |
| Mdxhealth | 5.760% | - | - | - | - | - | - |
| Isoray Inc. | 5.670% | -8.125% | 5.000% | 258.537% | 256.796% | 124.427% | 266.584% |